Sustained renal response with belimumab in children with new-onset lupus nephritis
Adding belimumab to standard treatment may effectively maintain long-term kidney function and reduce LN flares, making it an effective and safe biologic agent.
Authors
- Zhengkun Xia (ORCID: https://orcid.org/0000-0003-3281-8766)
- Qianhuining Kuang
- Tao Sun (ORCID: https://orcid.org/0000-0002-4204-0372)
- Zhuo Shi (ORCID: https://orcid.org/0000-0003-4946-2153)
- Xiang Fang (ORCID: https://orcid.org/0000-0001-6958-3775)
- Chunlin Gao
- Ren Wang (ORCID: https://orcid.org/0000-0003-1317-6593)
- Jun Yao (ORCID: https://orcid.org/0000-0003-2682-8650)
- Pei Zhang (ORCID: https://orcid.org/0009-0009-5063-3512)
- Jingjing Wang (ORCID: https://orcid.org/0000-0003-4318-6899)
- Yu Zhou
- Zhiqiang Zhang
- X. B. Yang (ORCID: https://orcid.org/0000-0003-1826-6141)
Institutions
- Nanjing General Hospital of Nanjing Military Command (CN)
- Jinling Institute of Technology (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Journal of Nephrology
- Published
- 2025-11-13
- DOI
- https://doi.org/10.1007/s40620-025-02397-0
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00